The microorganisms most commonly encountered in biliary tract infections have been studied by others (4, 9) . Cephalothin has effective antibacterial activity against most of these bacterial species, but its efficacy in treating biliary tract infections has not been studied clinically. Indeed, until recently, little was known of the pharmacology of cephalothin in the human biliary tree. Recently reported studies have used limited numbers of patients (1, 5) . In the present study a large number of patients were used in an attempt to clarify the pharmacology of cephalothin in the biliary tract of humans.
MATERIALS AND METHODS
Patients. A total of 126 patients were studied. Group 1 was comprised of 104 patients who were about to undergo cholecystectomy, and group 2 was comprised of 22 patients who had had cholecystectomies with common bile duct exploration followed by insertion of a T-tube. There were 35 males and 91 females, with ages ranging from 19 to 86 years. Hepatic, renal, and hematological status were determined in all patients.
Collection of specimens. In group 1, bile was aspirated from the gall bladder at operation at a recorded interval after the intravenous infusion of cephalothin. Blood samples were drawn before cephalothin administration and at the time of the bile sampling. In group 2, T-tube bile was collected by allowing it to drain into sterile glass tubes or by aspiration with a sterile syringe. Blood was drawn at designated intervals after cephalothin infusion. Bile samples were centrifuged at 49,000 x g for 15 min in a Sorvall RC2-B refrigerated centrifuge and the supernatant fluids were frozen at -70 C. Blood samples were allowed to clot and the sera were frozen at -70 C.
Cephalothin assay. Cephalothin was assayed by an agar diffusion method as described by Sabath et al. (7) . Six milliliters of a suspension of Bacillus globigii (5 x 10' cells/ml) was added to 100 ml of melted 1.5% Mueller-Hinton agar at 56 C, then dispensed in 20-ml amounts in plastic petri dishes (150 by 15 mm) and permitted to harden. Plates were stored at 4 C in plastic bags and used within 10 days. Assay procedures. Blank sterile paper disks (6.35 mm; BBL, Clarkson, Ontario) were spotted with 25 uliters of the antibiotic standards or unknown specimen and applied to the agar surface. Preliminary zone diameters were determined after a 5-h incubation period at 37 C. The final assay was performed with a second portion, using standards of 1.25, 2.5, and 5.0 jsg/ml; 10.0, 12.5, and 15 tg/ml; 10.0, 15.0, and 30.0 ;sg/ml; or 12.5, 25.0, and 50.0 sg/ml, so that in all cases except where the value exceeded 50.0 ;g/ml or was less than 1.25 ;&g/ml, it fell between that of the maximal and minimal standards. The dose response curves also followed the method of Sabath et al. (7) . The validity of the assay was plus or minus 25%, and the lower limit of measurable cephalothin was 0.1 Atg/ml.
Cephalothin dosages. The majority of patients received a single intravenous infusion of 1 g of cephalothin in 50 ml of 5% glucose in water before biliary surgery or T-tube cholangiogram. Four patients received 1 g of cephalothin every 6 h for five doses before sampling the T-tube bile. Twelve patients received 2 g of cephalothin intravenously before cholecystectomy, and two patients with T-tubes received 2 g of cephalothin intravenously before sampling.
RESULTS
Serum and gall bladder cephalothin levels.
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In patients receiving 2 g of cephalothin (Fig.   lb) , the mean level at 60 min was 8.6 Ag/ml; earlier blood samples were not taken. In only 13 patients (12.5%) were serum cephalothin levels equal to or greater than 25 gg/ml observed, and all these bloods were drawn less than 60 min after cephalothin administration ( Table 1) . The mean bile level at its peak among patients receiving 1 g of cephalothin was 7.6 ,gg/ml at 120 min (Fig. 2a) ; the mean bile level at 120 min for those patients receiving 2 g of cephalothin was 8.9 Ag/ml (Fig. 2b) . The gall bladder bile cephalothin levels ( Table 2 ). For those receiving 1 g of cephalothin, the mean at 60 min was 10.5 jig/ml in patients on a single dose (Fig. 3a ) and 7.2 ;tg/ml in patients given multiple doses (Fig. 3b) . The mean serum level at 60 min for the two patients receiving multiple doses of 2 g of cephalothin was 10.0 ,ug/ml (Fig. 3c) . The peak biliary level occurred at 1 h in all but two patients ( Table 2) ,/ml at 1 h and 0.3 ,g/ml at 4 h (Fig. 4a) . None of these patients had a bile level of more than 15
;&g/ml ( Table 2 ). Three of the four patients given multiple doses of 1 g of cephalothin had
bile levels of more than 15 gg/ml, but none exceeded 25.7 tg/ml; the mean level at 1 h was 12 &g/ml, and the mean at 4 h was 1.4 jsg/ml (Fig. 4b) . One of the two patients receiving multiple doses of 2 g of cephalothin had a bile level of more than 15 jsg/ml, but neither had a biliary level of more than 25 j.g/ml. The mean bile cephalothin level at 60 min in these two patients was 9.9 ,ug/ml (Fig. 4c) . (with the exception of Enterococcus) were susceptible to cephalothin in the minimal inhibitory concentration range of 0.01 to 6.3 ,ug/ml. However, many gram-negative rods (with the exception of Salmonella, Proteus mirabilis, and Haemophilus influenza) required minimal inhibitory concentration levels of 25 ,ug/ml or more. Based on this information, a serum or bile level of at least 25 ug/ml or more would be desirable to inhibit most gram-negative organisms. Our data would suggest that at the dosage used in this study, cephalothin would not be the drug of choice in biliary tract infections due to gram-negative rods since adequate serum and gall bladder cephalothin levels were attained in only 12.5 and 1.9%, respectively, in patients in group 1. Similarly, in group 2, serum and common duct levels were adequate in only 9.1 and 4.6% of patients, respectively. (4) and mean (0) after five doses of I g every 6 h to four patients. (c) Range (4) LITERATURE CITED
